Unfolding the rarity of SMARCA4 deficient uterine sarcoma (SDUS): A case report

被引:1
作者
Baa, Annie Kanchan [1 ]
Rastogi, Sameer [1 ]
Tripathy, Sarthak [2 ]
Shamim, Shamim Ahmed [2 ]
Menon, Santosh [3 ]
机构
[1] All India Inst Med Sci, Dept Med Oncol, New Delhi, India
[2] All India Inst Med Sci, Dept Nucl Med, New Delhi, India
[3] Tata Mem Hosp, Dept Pathol, Mumbai, Maharashtra, India
来源
GYNECOLOGIC ONCOLOGY REPORTS | 2021年 / 37卷
关键词
Sarcoma; Aggressive; PET-CT; Immunohistochemistry; Germline mutation; Chemotherapy; SMALL-CELL CARCINOMA; HYPERCALCEMIC TYPE; OVARY;
D O I
10.1016/j.gore.2021.100788
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Background: SMARCA4 deficient uterine sarcoma (SDUS) is a relatively new entity added to the family of uterine sarcoma characterised by SMARCA4/BRG1 deficiency. Case: A 62 years old lady presented with abdominal pain and vaginal discharge. On evaluation, found to have a pelvic mass with lymph nodal involvement. She underwent hysterectomy with bilateral salpingo-oophorectomy and lymphadenectomy. Preliminary diagnosis made outside was endometrial stromal sarcoma. On further review, had epithelioid and rhabdoid morphology with SMARCA4 loss documented on comprehensive gene profiling. Recurrence within few months of surgery was seen. She was started on gemcitabine and taxol based chemotherapy, showing significant clinical and radiological improvement. Conclusion: Diagnostic dilemma of this infrequent, aggressive subtype of uterine sarcoma adds to the hindrance in early recognition. Identifying histology surmounted with gene profiling is helpful in establishing diagnosis resulting in early treatment and improving outcomes.
引用
收藏
页数:4
相关论文
共 11 条
  • [1] Selective Killing of SMARCA2-and SMARCA4-deficient Small Cell Carcinoma of the Ovary, Hypercalcemic Type Cells by Inhibition of EZH2: In Vitro and In Vivo Preclinical Models
    Chan-Penebre, Elayne
    Armstrong, Kelli
    Drew, Allison
    Grassian, Alexandra R.
    Feldman, Igor
    Knutson, Sarah K.
    Kuplast-Barr, Kristy
    Roche, Maria
    Campbell, John
    Ho, Peter
    Copeland, Robert A.
    Chesworth, Richard
    Smith, Jesse J.
    Keilhack, Heike
    Ribich, Scott A.
    [J]. MOLECULAR CANCER THERAPEUTICS, 2017, 16 (05) : 850 - 860
  • [2] Connor YD, 2020, GYNECOL ONCOL, V159, P131, DOI [10.1016/j.ygyno.2020.05.164, 10.1016/j.ygyno.2019.10.031]
  • [3] Randomized Comparison of Pazopanib and Doxorubicin as First-Line Treatment in Patients With Metastatic Soft Tissue Sarcoma Age 60 Years or Older: Results of a German Intergroup Study
    Gruenwald, Viktor
    Karch, Annika
    Schuler, Markus
    Schoeffski, Patrick
    Kopp, Hans-Georg
    Bauer, Sebastian
    Kasper, Bernd
    Lindner, Lars H.
    Chemnitz, Jens-Marcus
    Crysandt, Martina
    Stein, Alexander
    Steffen, Bjoern
    Richter, Stephan
    Egerer, Gerlinde
    Ivanyi, Philipp
    Zimmermann, Silke
    Liu, Xiaofei
    Kunitz, Annegret
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (30) : 3555 - +
  • [4] Immune-Active Microenvironment in Small Cell Carcinoma of the Ovary, Hypercalcemic Type: Rationale for Immune Checkpoint Blockade
    Jelinic, Petar
    Ricca, Jacob
    Van Oudenhove, Elke
    Olvera, Narciso
    Merghoub, Taha
    Levine, Douglas A.
    Zamarin, Dmitriy
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2018, 110 (07): : 787 - 790
  • [5] SMARCA4-deficient Uterine Sarcoma and Undifferentiated Endometrial Carcinoma Are Distinct Clinicopathologic Entities
    Kolin, David L.
    Quick, Charles M.
    Dong, Fei
    Fletcher, Christopher D. M.
    Stewart, Colin J. R.
    Soma, Anita
    Hornick, Jason L.
    Nucci, Marisa R.
    Howitt, Brooke E.
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2020, 44 (02) : 263 - 270
  • [6] SMARCA4-deficient undifferentiated uterine sarcoma (malignant rhabdoid tumor of the uterus): a clinicopathologic entity distinct from undifferentiated carcinoma
    Kolin, David L.
    Dong, Fei
    Baltay, Michele
    Lindeman, Neal
    MacConaill, Laura
    Nucci, Marisa R.
    Crum, Christopher P.
    Howitt, Brooke E.
    [J]. MODERN PATHOLOGY, 2018, 31 (09) : 1442 - 1456
  • [7] Kord Ali, 2020, Case Rep Womens Health, V27, pe00231, DOI 10.1016/j.crwh.2020.e00231
  • [8] SMARCA4 inactivation defines a subset of undifferentiated uterine sarcomas with rhabdoid and small cell features and germline mutation association
    Lin, Douglas I.
    Allen, Justin M.
    Hecht, Jonathan L.
    Killian, Jonathan K.
    Ngo, Nhu T.
    Edgerly, Claire
    Severson, Eric A.
    Ali, Siraj M.
    Erlich, Rachel L.
    Ramkissoon, Shakti H.
    Vergilio, Jo-Anne
    Ross, Jeffrey S.
    Elvin, Julia A.
    [J]. MODERN PATHOLOGY, 2019, 32 (11) : 1675 - 1687
  • [9] Uterine mesenchymal tumours: recent advances
    Momeni-Boroujeni, Amir
    Chiang, Sarah
    [J]. HISTOPATHOLOGY, 2020, 76 (01) : 64 - 75
  • [10] Muppala R, 2017, GYNECOL ONCOL REP, V22, P45, DOI 10.1016/j.gore.2017.09.010